nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ABCC2—Sulfasalazine—Crohn's disease	0.135	0.318	CbGbCtD
Tamoxifen—ABCG2—Sulfasalazine—Crohn's disease	0.122	0.288	CbGbCtD
Tamoxifen—CYP3A5—Sulfasalazine—Crohn's disease	0.0675	0.159	CbGbCtD
Tamoxifen—CYP2C19—Prednisone—Crohn's disease	0.0435	0.103	CbGbCtD
Tamoxifen—ABCB1—Prednisone—Crohn's disease	0.0351	0.0829	CbGbCtD
Tamoxifen—Sarcoma—Azathioprine—Crohn's disease	0.0348	0.0973	CcSEcCtD
Tamoxifen—ABCB11—bile—Crohn's disease	0.0265	0.147	CbGeAlD
Tamoxifen—CYP3A4—Prednisone—Crohn's disease	0.021	0.0497	CbGbCtD
Tamoxifen—Peliosis hepatis—Azathioprine—Crohn's disease	0.0167	0.0467	CcSEcCtD
Tamoxifen—ABCC2—bile—Crohn's disease	0.0135	0.0747	CbGeAlD
Tamoxifen—UGT1A4—mouth—Crohn's disease	0.00917	0.0509	CbGeAlD
Tamoxifen—EBPL—epithelium—Crohn's disease	0.00769	0.0427	CbGeAlD
Tamoxifen—Myelosuppression—Mercaptopurine—Crohn's disease	0.00751	0.021	CcSEcCtD
Tamoxifen—Hepatic necrosis—Mercaptopurine—Crohn's disease	0.00606	0.0169	CcSEcCtD
Tamoxifen—Polyp—Mercaptopurine—Crohn's disease	0.00579	0.0162	CcSEcCtD
Tamoxifen—CES1—gall bladder—Crohn's disease	0.00573	0.0318	CbGeAlD
Tamoxifen—Breast feeding—Mesalazine—Crohn's disease	0.00547	0.0153	CcSEcCtD
Tamoxifen—Cyst—Mercaptopurine—Crohn's disease	0.00527	0.0147	CcSEcCtD
Tamoxifen—SULT1A1—digestive system—Crohn's disease	0.00465	0.0258	CbGeAlD
Tamoxifen—Cholestasis—Mercaptopurine—Crohn's disease	0.00464	0.0129	CcSEcCtD
Tamoxifen—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.00456	0.0127	CcSEcCtD
Tamoxifen—Myelosuppression—Azathioprine—Crohn's disease	0.00447	0.0125	CcSEcCtD
Tamoxifen—Interstitial pneumonia—Azathioprine—Crohn's disease	0.00434	0.0121	CcSEcCtD
Tamoxifen—Liver injury—Mercaptopurine—Crohn's disease	0.00418	0.0117	CcSEcCtD
Tamoxifen—DHCR7—skin of body—Crohn's disease	0.00413	0.023	CbGeAlD
Tamoxifen—UGT1A4—digestive system—Crohn's disease	0.00406	0.0225	CbGeAlD
Tamoxifen—Interstitial pneumonia—Mesalazine—Crohn's disease	0.00395	0.011	CcSEcCtD
Tamoxifen—DHCR7—mammalian vulva—Crohn's disease	0.00377	0.0209	CbGeAlD
Tamoxifen—FMO1—mammalian vulva—Crohn's disease	0.00377	0.0209	CbGeAlD
Tamoxifen—ESRRA—mammalian vulva—Crohn's disease	0.00371	0.0206	CbGeAlD
Tamoxifen—Vulvovaginal candidiasis—Mesalazine—Crohn's disease	0.00363	0.0102	CcSEcCtD
Tamoxifen—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.00352	0.00983	CcSEcCtD
Tamoxifen—Polyp—Azathioprine—Crohn's disease	0.00345	0.00963	CcSEcCtD
Tamoxifen—DHCR7—lymphoid tissue—Crohn's disease	0.00335	0.0186	CbGeAlD
Tamoxifen—EBPL—lymph node—Crohn's disease	0.00334	0.0186	CbGeAlD
Tamoxifen—DHCR7—digestive system—Crohn's disease	0.00331	0.0184	CbGeAlD
Tamoxifen—FMO1—digestive system—Crohn's disease	0.00331	0.0184	CbGeAlD
Tamoxifen—Hepatic necrosis—Mesalazine—Crohn's disease	0.00329	0.00918	CcSEcCtD
Tamoxifen—FMO3—mammalian vulva—Crohn's disease	0.00326	0.0181	CbGeAlD
Tamoxifen—ESRRA—digestive system—Crohn's disease	0.00326	0.0181	CbGeAlD
Tamoxifen—Platelet count decreased—Mesalazine—Crohn's disease	0.00321	0.00897	CcSEcCtD
Tamoxifen—Neoplasm—Mercaptopurine—Crohn's disease	0.00318	0.00889	CcSEcCtD
Tamoxifen—Cyst—Azathioprine—Crohn's disease	0.00314	0.00877	CcSEcCtD
Tamoxifen—Sepsis—Mercaptopurine—Crohn's disease	0.00306	0.00853	CcSEcCtD
Tamoxifen—Interstitial lung disease—Azathioprine—Crohn's disease	0.00296	0.00828	CcSEcCtD
Tamoxifen—Nail disorder—Mesalazine—Crohn's disease	0.00295	0.00823	CcSEcCtD
Tamoxifen—Upset stomach—Mesalazine—Crohn's disease	0.00292	0.00815	CcSEcCtD
Tamoxifen—ABCB11—digestive system—Crohn's disease	0.00289	0.016	CbGeAlD
Tamoxifen—Abdominal cramps—Mesalazine—Crohn's disease	0.00283	0.00791	CcSEcCtD
Tamoxifen—Cholestasis—Azathioprine—Crohn's disease	0.00276	0.00772	CcSEcCtD
Tamoxifen—Hepatotoxicity—Azathioprine—Crohn's disease	0.00272	0.00759	CcSEcCtD
Tamoxifen—Thrombosis—Mesalazine—Crohn's disease	0.0027	0.00754	CcSEcCtD
Tamoxifen—Interstitial lung disease—Mesalazine—Crohn's disease	0.0027	0.00754	CcSEcCtD
Tamoxifen—SULT1A1—lymph node—Crohn's disease	0.00266	0.0147	CbGeAlD
Tamoxifen—Blister—Mesalazine—Crohn's disease	0.00265	0.0074	CcSEcCtD
Tamoxifen—ESR2—epithelium—Crohn's disease	0.00257	0.0143	CbGeAlD
Tamoxifen—Cholestasis—Mesalazine—Crohn's disease	0.00252	0.00703	CcSEcCtD
Tamoxifen—Liver injury—Azathioprine—Crohn's disease	0.00249	0.00696	CcSEcCtD
Tamoxifen—Hepatotoxicity—Mesalazine—Crohn's disease	0.00247	0.00691	CcSEcCtD
Tamoxifen—ESR2—smooth muscle tissue—Crohn's disease	0.00247	0.0137	CbGeAlD
Tamoxifen—CYP1A1—mouth—Crohn's disease	0.0023	0.0128	CbGeAlD
Tamoxifen—CES1—lymphoid tissue—Crohn's disease	0.00228	0.0127	CbGeAlD
Tamoxifen—Liver injury—Mesalazine—Crohn's disease	0.00227	0.00634	CcSEcCtD
Tamoxifen—CES1—digestive system—Crohn's disease	0.00226	0.0125	CbGeAlD
Tamoxifen—Tenderness—Mesalazine—Crohn's disease	0.00219	0.00612	CcSEcCtD
Tamoxifen—Breast pain—Mesalazine—Crohn's disease	0.00219	0.00612	CcSEcCtD
Tamoxifen—Amenorrhoea—Mesalazine—Crohn's disease	0.00217	0.00607	CcSEcCtD
Tamoxifen—Pancreatitis—Mercaptopurine—Crohn's disease	0.00217	0.00605	CcSEcCtD
Tamoxifen—Vasculitis—Azathioprine—Crohn's disease	0.00215	0.006	CcSEcCtD
Tamoxifen—Arthropathy—Mesalazine—Crohn's disease	0.0021	0.00587	CcSEcCtD
Tamoxifen—Hepatocellular injury—Azathioprine—Crohn's disease	0.0021	0.00586	CcSEcCtD
Tamoxifen—Pancytopenia—Mercaptopurine—Crohn's disease	0.0021	0.00586	CcSEcCtD
Tamoxifen—Cough increased—Mesalazine—Crohn's disease	0.00209	0.00583	CcSEcCtD
Tamoxifen—Blood bilirubin increased—Mesalazine—Crohn's disease	0.00202	0.00564	CcSEcCtD
Tamoxifen—ESR2—lymphoid tissue—Crohn's disease	0.00198	0.011	CbGeAlD
Tamoxifen—ESR2—digestive system—Crohn's disease	0.00195	0.0108	CbGeAlD
Tamoxifen—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00193	0.0054	CcSEcCtD
Tamoxifen—SIGMAR1—smooth muscle tissue—Crohn's disease	0.00192	0.0106	CbGeAlD
Tamoxifen—Hepatocellular injury—Mesalazine—Crohn's disease	0.00191	0.00534	CcSEcCtD
Tamoxifen—Vaginal inflammation—Mesalazine—Crohn's disease	0.00191	0.00534	CcSEcCtD
Tamoxifen—Neoplasm—Azathioprine—Crohn's disease	0.0019	0.0053	CcSEcCtD
Tamoxifen—DHCR7—lymph node—Crohn's disease	0.00189	0.0105	CbGeAlD
Tamoxifen—FMO1—lymph node—Crohn's disease	0.00189	0.0105	CbGeAlD
Tamoxifen—ESRRA—lymph node—Crohn's disease	0.00186	0.0103	CbGeAlD
Tamoxifen—Menstruation irregular—Prednisone—Crohn's disease	0.00183	0.0051	CcSEcCtD
Tamoxifen—Skin exfoliation—Mesalazine—Crohn's disease	0.00182	0.0051	CcSEcCtD
Tamoxifen—CYP1B1—smooth muscle tissue—Crohn's disease	0.00182	0.0101	CbGeAlD
Tamoxifen—Vaginal infection—Mesalazine—Crohn's disease	0.0018	0.00504	CcSEcCtD
Tamoxifen—Osteoporosis—Prednisone—Crohn's disease	0.0018	0.00504	CcSEcCtD
Tamoxifen—CYP1B1—skin of body—Crohn's disease	0.0018	0.00999	CbGeAlD
Tamoxifen—Hypertriglyceridaemia—Prednisone—Crohn's disease	0.00176	0.00492	CcSEcCtD
Tamoxifen—ESR1—epithelium—Crohn's disease	0.00176	0.00977	CbGeAlD
Tamoxifen—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00176	0.0049	CcSEcCtD
Tamoxifen—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00174	0.00487	CcSEcCtD
Tamoxifen—Multiple fractures—Prednisone—Crohn's disease	0.00174	0.00486	CcSEcCtD
Tamoxifen—Fracture—Prednisone—Crohn's disease	0.00174	0.00486	CcSEcCtD
Tamoxifen—SIGMAR1—mammalian vulva—Crohn's disease	0.00173	0.00958	CbGeAlD
Tamoxifen—ESR1—smooth muscle tissue—Crohn's disease	0.00169	0.00941	CbGeAlD
Tamoxifen—Hepatic failure—Azathioprine—Crohn's disease	0.00169	0.00473	CcSEcCtD
Tamoxifen—Febrile neutropenia—Prednisone—Crohn's disease	0.00168	0.00469	CcSEcCtD
Tamoxifen—Optic neuritis—Prednisone—Crohn's disease	0.00164	0.00459	CcSEcCtD
Tamoxifen—FMO3—lymph node—Crohn's disease	0.00163	0.00906	CbGeAlD
Tamoxifen—Embolism—Prednisone—Crohn's disease	0.00157	0.0044	CcSEcCtD
Tamoxifen—Alopecia—Mercaptopurine—Crohn's disease	0.00156	0.00436	CcSEcCtD
Tamoxifen—Hepatic failure—Mesalazine—Crohn's disease	0.00154	0.00431	CcSEcCtD
Tamoxifen—Blood triglycerides increased—Prednisone—Crohn's disease	0.00154	0.00431	CcSEcCtD
Tamoxifen—ABCC2—digestive system—Crohn's disease	0.00147	0.00816	CbGeAlD
Tamoxifen—Thirst—Mesalazine—Crohn's disease	0.00146	0.00407	CcSEcCtD
Tamoxifen—CYP1B1—lymphoid tissue—Crohn's disease	0.00146	0.00809	CbGeAlD
Tamoxifen—Dermatitis bullous—Mesalazine—Crohn's disease	0.00145	0.00405	CcSEcCtD
Tamoxifen—CYP1B1—digestive system—Crohn's disease	0.00144	0.00799	CbGeAlD
Tamoxifen—Arthritis—Mesalazine—Crohn's disease	0.00143	0.00399	CcSEcCtD
Tamoxifen—Anaemia—Mercaptopurine—Crohn's disease	0.00142	0.00397	CcSEcCtD
Tamoxifen—Osteoarthritis—Mesalazine—Crohn's disease	0.00139	0.00387	CcSEcCtD
Tamoxifen—Leukopenia—Mercaptopurine—Crohn's disease	0.00138	0.00385	CcSEcCtD
Tamoxifen—ESR1—lymphoid tissue—Crohn's disease	0.00135	0.00752	CbGeAlD
Tamoxifen—ESR1—digestive system—Crohn's disease	0.00134	0.00743	CbGeAlD
Tamoxifen—CYP1A1—epithelium—Crohn's disease	0.00134	0.00743	CbGeAlD
Tamoxifen—Mood swings—Mesalazine—Crohn's disease	0.00131	0.00367	CcSEcCtD
Tamoxifen—Arthralgia—Mercaptopurine—Crohn's disease	0.00131	0.00366	CcSEcCtD
Tamoxifen—Blood creatinine increased—Mesalazine—Crohn's disease	0.0013	0.00363	CcSEcCtD
Tamoxifen—Pancreatitis—Azathioprine—Crohn's disease	0.00129	0.0036	CcSEcCtD
Tamoxifen—CES1—lymph node—Crohn's disease	0.00129	0.00716	CbGeAlD
Tamoxifen—Liver function test abnormal—Mesalazine—Crohn's disease	0.00128	0.00358	CcSEcCtD
Tamoxifen—CYP1A1—skin of body—Crohn's disease	0.00127	0.00706	CbGeAlD
Tamoxifen—CYP2C19—digestive system—Crohn's disease	0.00126	0.00701	CbGeAlD
Tamoxifen—Abdominal discomfort—Azathioprine—Crohn's disease	0.00126	0.00352	CcSEcCtD
Tamoxifen—Oedema—Mercaptopurine—Crohn's disease	0.00126	0.00351	CcSEcCtD
Tamoxifen—Pancytopenia—Azathioprine—Crohn's disease	0.00125	0.00349	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00125	0.00349	CcSEcCtD
Tamoxifen—Cramp muscle—Mesalazine—Crohn's disease	0.00125	0.00349	CcSEcCtD
Tamoxifen—CYP2B6—skin of body—Crohn's disease	0.00124	0.00686	CbGeAlD
Tamoxifen—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00123	0.00344	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00122	0.00342	CcSEcCtD
Tamoxifen—ABCG2—mammalian vulva—Crohn's disease	0.00122	0.00679	CbGeAlD
Tamoxifen—Dysphagia—Mesalazine—Crohn's disease	0.0012	0.00335	CcSEcCtD
Tamoxifen—Influenza—Mesalazine—Crohn's disease	0.0012	0.00335	CcSEcCtD
Tamoxifen—Anorexia—Mercaptopurine—Crohn's disease	0.0012	0.00334	CcSEcCtD
Tamoxifen—Pneumonia—Azathioprine—Crohn's disease	0.00118	0.0033	CcSEcCtD
Tamoxifen—Pancreatitis—Mesalazine—Crohn's disease	0.00118	0.00328	CcSEcCtD
Tamoxifen—Angina pectoris—Mesalazine—Crohn's disease	0.00117	0.00326	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00116	0.00325	CcSEcCtD
Tamoxifen—CYP1A1—mammalian vulva—Crohn's disease	0.00116	0.00644	CbGeAlD
Tamoxifen—Contusion—Prednisone—Crohn's disease	0.00116	0.00324	CcSEcCtD
Tamoxifen—Bronchitis—Mesalazine—Crohn's disease	0.00115	0.00322	CcSEcCtD
Tamoxifen—Amenorrhoea—Prednisone—Crohn's disease	0.00115	0.00321	CcSEcCtD
Tamoxifen—Abdominal discomfort—Mesalazine—Crohn's disease	0.00115	0.00321	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00114	0.0032	CcSEcCtD
Tamoxifen—Pancytopenia—Mesalazine—Crohn's disease	0.00114	0.00318	CcSEcCtD
Tamoxifen—Neutropenia—Mesalazine—Crohn's disease	0.00112	0.00313	CcSEcCtD
Tamoxifen—ESR2—lymph node—Crohn's disease	0.00112	0.0062	CbGeAlD
Tamoxifen—Arthropathy—Prednisone—Crohn's disease	0.00111	0.00311	CcSEcCtD
Tamoxifen—Decreased appetite—Mercaptopurine—Crohn's disease	0.00109	0.00305	CcSEcCtD
Tamoxifen—Weight increased—Mesalazine—Crohn's disease	0.00109	0.00305	CcSEcCtD
Tamoxifen—Weight decreased—Mesalazine—Crohn's disease	0.00108	0.00303	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00108	0.00303	CcSEcCtD
Tamoxifen—Pneumonia—Mesalazine—Crohn's disease	0.00108	0.003	CcSEcCtD
Tamoxifen—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00107	0.00299	CcSEcCtD
Tamoxifen—Depression—Mesalazine—Crohn's disease	0.00107	0.00298	CcSEcCtD
Tamoxifen—Cataract—Prednisone—Crohn's disease	0.00106	0.00297	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00106	0.00296	CcSEcCtD
Tamoxifen—Haemoglobin—Azathioprine—Crohn's disease	0.00106	0.00296	CcSEcCtD
Tamoxifen—Haemorrhage—Azathioprine—Crohn's disease	0.00105	0.00294	CcSEcCtD
Tamoxifen—Urinary tract infection—Mesalazine—Crohn's disease	0.00104	0.0029	CcSEcCtD
Tamoxifen—Vasculitis—Prednisone—Crohn's disease	0.00104	0.00289	CcSEcCtD
Tamoxifen—CYP1A2—digestive system—Crohn's disease	0.00103	0.00573	CbGeAlD
Tamoxifen—Sweating—Mesalazine—Crohn's disease	0.00102	0.00286	CcSEcCtD
Tamoxifen—CYP1A1—digestive system—Crohn's disease	0.00102	0.00565	CbGeAlD
Tamoxifen—Sinusitis—Mesalazine—Crohn's disease	0.001	0.0028	CcSEcCtD
Tamoxifen—CYP2B6—lymphoid tissue—Crohn's disease	0.001	0.00556	CbGeAlD
Tamoxifen—Erythema multiforme—Azathioprine—Crohn's disease	0.000996	0.00278	CcSEcCtD
Tamoxifen—CYP3A5—digestive system—Crohn's disease	0.000995	0.00552	CbGeAlD
Tamoxifen—CYP2B6—digestive system—Crohn's disease	0.000989	0.00549	CbGeAlD
Tamoxifen—CYP2C9—digestive system—Crohn's disease	0.000979	0.00544	CbGeAlD
Tamoxifen—Skin exfoliation—Prednisone—Crohn's disease	0.000965	0.0027	CcSEcCtD
Tamoxifen—Haemoglobin—Mesalazine—Crohn's disease	0.000964	0.00269	CcSEcCtD
Tamoxifen—Fluid retention—Prednisone—Crohn's disease	0.00096	0.00268	CcSEcCtD
Tamoxifen—Haemorrhage—Mesalazine—Crohn's disease	0.00096	0.00268	CcSEcCtD
Tamoxifen—Hepatitis—Mesalazine—Crohn's disease	0.00096	0.00268	CcSEcCtD
Tamoxifen—Pharyngitis—Mesalazine—Crohn's disease	0.000952	0.00266	CcSEcCtD
Tamoxifen—Oedema peripheral—Mesalazine—Crohn's disease	0.000945	0.00264	CcSEcCtD
Tamoxifen—Arrhythmia—Azathioprine—Crohn's disease	0.000941	0.00263	CcSEcCtD
Tamoxifen—CYP2E1—lymphoid tissue—Crohn's disease	0.000939	0.00522	CbGeAlD
Tamoxifen—Alopecia—Azathioprine—Crohn's disease	0.000931	0.0026	CcSEcCtD
Tamoxifen—CYP2E1—digestive system—Crohn's disease	0.000928	0.00515	CbGeAlD
Tamoxifen—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000925	0.00258	CcSEcCtD
Tamoxifen—Erythema multiforme—Mesalazine—Crohn's disease	0.000907	0.00253	CcSEcCtD
Tamoxifen—CYP19A1—lymph node—Crohn's disease	0.000879	0.00488	CbGeAlD
Tamoxifen—Sepsis—Prednisone—Crohn's disease	0.000877	0.00245	CcSEcCtD
Tamoxifen—SIGMAR1—lymph node—Crohn's disease	0.000865	0.0048	CbGeAlD
Tamoxifen—Diarrhoea—Mercaptopurine—Crohn's disease	0.000859	0.0024	CcSEcCtD
Tamoxifen—Alopecia—Mesalazine—Crohn's disease	0.000848	0.00237	CcSEcCtD
Tamoxifen—Anaemia—Azathioprine—Crohn's disease	0.000848	0.00237	CcSEcCtD
Tamoxifen—ABCC2—lymph node—Crohn's disease	0.000839	0.00466	CbGeAlD
Tamoxifen—Erythema—Mesalazine—Crohn's disease	0.000835	0.00233	CcSEcCtD
Tamoxifen—CYP1B1—lymph node—Crohn's disease	0.000822	0.00457	CbGeAlD
Tamoxifen—Leukopenia—Azathioprine—Crohn's disease	0.000821	0.00229	CcSEcCtD
Tamoxifen—Dysgeusia—Mesalazine—Crohn's disease	0.000818	0.00228	CcSEcCtD
Tamoxifen—Back pain—Mesalazine—Crohn's disease	0.000808	0.00226	CcSEcCtD
Tamoxifen—Muscle spasms—Mesalazine—Crohn's disease	0.000803	0.00224	CcSEcCtD
Tamoxifen—Vomiting—Mercaptopurine—Crohn's disease	0.000799	0.00223	CcSEcCtD
Tamoxifen—Injury—Prednisone—Crohn's disease	0.000798	0.00223	CcSEcCtD
Tamoxifen—Rash—Mercaptopurine—Crohn's disease	0.000792	0.00221	CcSEcCtD
Tamoxifen—Dermatitis—Mercaptopurine—Crohn's disease	0.000791	0.00221	CcSEcCtD
Tamoxifen—Arthralgia—Azathioprine—Crohn's disease	0.000781	0.00218	CcSEcCtD
Tamoxifen—Myalgia—Azathioprine—Crohn's disease	0.000781	0.00218	CcSEcCtD
Tamoxifen—Anaemia—Mesalazine—Crohn's disease	0.000772	0.00216	CcSEcCtD
Tamoxifen—Discomfort—Azathioprine—Crohn's disease	0.000771	0.00215	CcSEcCtD
Tamoxifen—ESR1—lymph node—Crohn's disease	0.000764	0.00424	CbGeAlD
Tamoxifen—Angioedema—Mesalazine—Crohn's disease	0.000763	0.00213	CcSEcCtD
Tamoxifen—Leukopenia—Mesalazine—Crohn's disease	0.000748	0.00209	CcSEcCtD
Tamoxifen—CYP3A4—digestive system—Crohn's disease	0.000747	0.00415	CbGeAlD
Tamoxifen—Nausea—Mercaptopurine—Crohn's disease	0.000746	0.00208	CcSEcCtD
Tamoxifen—Infection—Azathioprine—Crohn's disease	0.000744	0.00208	CcSEcCtD
Tamoxifen—CYP2D6—digestive system—Crohn's disease	0.000735	0.00408	CbGeAlD
Tamoxifen—Osteoarthritis—Prednisone—Crohn's disease	0.000734	0.00205	CcSEcCtD
Tamoxifen—Thrombocytopenia—Azathioprine—Crohn's disease	0.000733	0.00205	CcSEcCtD
Tamoxifen—Cough—Mesalazine—Crohn's disease	0.000729	0.00204	CcSEcCtD
Tamoxifen—Hypertension—Mesalazine—Crohn's disease	0.000721	0.00201	CcSEcCtD
Tamoxifen—Chest pain—Mesalazine—Crohn's disease	0.000711	0.00199	CcSEcCtD
Tamoxifen—Myalgia—Mesalazine—Crohn's disease	0.000711	0.00199	CcSEcCtD
Tamoxifen—Arthralgia—Mesalazine—Crohn's disease	0.000711	0.00199	CcSEcCtD
Tamoxifen—Anxiety—Mesalazine—Crohn's disease	0.000709	0.00198	CcSEcCtD
Tamoxifen—Discomfort—Mesalazine—Crohn's disease	0.000703	0.00196	CcSEcCtD
Tamoxifen—Dry mouth—Mesalazine—Crohn's disease	0.000696	0.00194	CcSEcCtD
Tamoxifen—Mood swings—Prednisone—Crohn's disease	0.000695	0.00194	CcSEcCtD
Tamoxifen—ABCB1—epithelium—Crohn's disease	0.000695	0.00386	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000682	0.0019	CcSEcCtD
Tamoxifen—Oedema—Mesalazine—Crohn's disease	0.000682	0.0019	CcSEcCtD
Tamoxifen—Infection—Mesalazine—Crohn's disease	0.000677	0.00189	CcSEcCtD
Tamoxifen—Thrombocytopenia—Mesalazine—Crohn's disease	0.000667	0.00186	CcSEcCtD
Tamoxifen—Hyperhidrosis—Mesalazine—Crohn's disease	0.000659	0.00184	CcSEcCtD
Tamoxifen—Anorexia—Mesalazine—Crohn's disease	0.00065	0.00182	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000647	0.00181	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000646	0.0018	CcSEcCtD
Tamoxifen—Pancreatitis—Prednisone—Crohn's disease	0.000622	0.00174	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000621	0.00173	CcSEcCtD
Tamoxifen—Insomnia—Mesalazine—Crohn's disease	0.000617	0.00172	CcSEcCtD
Tamoxifen—ABCG2—lymph node—Crohn's disease	0.000612	0.0034	CbGeAlD
Tamoxifen—Paraesthesia—Mesalazine—Crohn's disease	0.000612	0.00171	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000612	0.00171	CcSEcCtD
Tamoxifen—Dyspnoea—Mesalazine—Crohn's disease	0.000608	0.0017	CcSEcCtD
Tamoxifen—ABCB1—mammalian vulva—Crohn's disease	0.000603	0.00335	CbGeAlD
Tamoxifen—Dyspepsia—Mesalazine—Crohn's disease	0.0006	0.00168	CcSEcCtD
Tamoxifen—Neutropenia—Prednisone—Crohn's disease	0.000593	0.00166	CcSEcCtD
Tamoxifen—Decreased appetite—Mesalazine—Crohn's disease	0.000593	0.00166	CcSEcCtD
Tamoxifen—Abdominal pain—Azathioprine—Crohn's disease	0.000592	0.00165	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000589	0.00164	CcSEcCtD
Tamoxifen—Fatigue—Mesalazine—Crohn's disease	0.000588	0.00164	CcSEcCtD
Tamoxifen—Erectile dysfunction—Prednisone—Crohn's disease	0.000584	0.00163	CcSEcCtD
Tamoxifen—Pain—Mesalazine—Crohn's disease	0.000583	0.00163	CcSEcCtD
Tamoxifen—Constipation—Mesalazine—Crohn's disease	0.000583	0.00163	CcSEcCtD
Tamoxifen—CYP1A1—lymph node—Crohn's disease	0.000581	0.00323	CbGeAlD
Tamoxifen—Weight increased—Prednisone—Crohn's disease	0.000577	0.00161	CcSEcCtD
Tamoxifen—Weight decreased—Prednisone—Crohn's disease	0.000574	0.0016	CcSEcCtD
Tamoxifen—Depression—Prednisone—Crohn's disease	0.000564	0.00158	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Prednisone—Crohn's disease	0.000558	0.00156	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000557	0.00156	CcSEcCtD
Tamoxifen—Myocardial infarction—Prednisone—Crohn's disease	0.000554	0.00155	CcSEcCtD
Tamoxifen—Hypersensitivity—Azathioprine—Crohn's disease	0.000551	0.00154	CcSEcCtD
Tamoxifen—Urticaria—Mesalazine—Crohn's disease	0.000542	0.00151	CcSEcCtD
Tamoxifen—Abdominal pain—Mesalazine—Crohn's disease	0.000539	0.00151	CcSEcCtD
Tamoxifen—ABCB1—lymphoid tissue—Crohn's disease	0.000535	0.00297	CbGeAlD
Tamoxifen—ABCB1—digestive system—Crohn's disease	0.000528	0.00293	CbGeAlD
Tamoxifen—Diarrhoea—Azathioprine—Crohn's disease	0.000512	0.00143	CcSEcCtD
Tamoxifen—Haemoglobin—Prednisone—Crohn's disease	0.00051	0.00143	CcSEcCtD
Tamoxifen—Haemorrhage—Prednisone—Crohn's disease	0.000508	0.00142	CcSEcCtD
Tamoxifen—Hypersensitivity—Mesalazine—Crohn's disease	0.000502	0.0014	CcSEcCtD
Tamoxifen—Dizziness—Azathioprine—Crohn's disease	0.000495	0.00138	CcSEcCtD
Tamoxifen—Asthenia—Mesalazine—Crohn's disease	0.000489	0.00137	CcSEcCtD
Tamoxifen—Pruritus—Mesalazine—Crohn's disease	0.000482	0.00135	CcSEcCtD
Tamoxifen—Vomiting—Azathioprine—Crohn's disease	0.000476	0.00133	CcSEcCtD
Tamoxifen—Rash—Azathioprine—Crohn's disease	0.000472	0.00132	CcSEcCtD
Tamoxifen—Dermatitis—Azathioprine—Crohn's disease	0.000471	0.00132	CcSEcCtD
Tamoxifen—Flushing—Prednisone—Crohn's disease	0.000471	0.00132	CcSEcCtD
Tamoxifen—Headache—Azathioprine—Crohn's disease	0.000469	0.00131	CcSEcCtD
Tamoxifen—Diarrhoea—Mesalazine—Crohn's disease	0.000466	0.0013	CcSEcCtD
Tamoxifen—Arrhythmia—Prednisone—Crohn's disease	0.000454	0.00127	CcSEcCtD
Tamoxifen—Dizziness—Mesalazine—Crohn's disease	0.000451	0.00126	CcSEcCtD
Tamoxifen—Alopecia—Prednisone—Crohn's disease	0.000449	0.00125	CcSEcCtD
Tamoxifen—Nausea—Azathioprine—Crohn's disease	0.000445	0.00124	CcSEcCtD
Tamoxifen—Erythema—Prednisone—Crohn's disease	0.000442	0.00123	CcSEcCtD
Tamoxifen—Vomiting—Mesalazine—Crohn's disease	0.000433	0.00121	CcSEcCtD
Tamoxifen—Rash—Mesalazine—Crohn's disease	0.00043	0.0012	CcSEcCtD
Tamoxifen—Dermatitis—Mesalazine—Crohn's disease	0.000429	0.0012	CcSEcCtD
Tamoxifen—Headache—Mesalazine—Crohn's disease	0.000427	0.00119	CcSEcCtD
Tamoxifen—Anaemia—Prednisone—Crohn's disease	0.000408	0.00114	CcSEcCtD
Tamoxifen—Nausea—Mesalazine—Crohn's disease	0.000405	0.00113	CcSEcCtD
Tamoxifen—Angioedema—Prednisone—Crohn's disease	0.000404	0.00113	CcSEcCtD
Tamoxifen—Hypertension—Prednisone—Crohn's disease	0.000382	0.00107	CcSEcCtD
Tamoxifen—Arthralgia—Prednisone—Crohn's disease	0.000376	0.00105	CcSEcCtD
Tamoxifen—Myalgia—Prednisone—Crohn's disease	0.000376	0.00105	CcSEcCtD
Tamoxifen—Anxiety—Prednisone—Crohn's disease	0.000375	0.00105	CcSEcCtD
Tamoxifen—Discomfort—Prednisone—Crohn's disease	0.000372	0.00104	CcSEcCtD
Tamoxifen—Oedema—Prednisone—Crohn's disease	0.000361	0.00101	CcSEcCtD
Tamoxifen—Infection—Prednisone—Crohn's disease	0.000358	0.001	CcSEcCtD
Tamoxifen—Hyperhidrosis—Prednisone—Crohn's disease	0.000349	0.000974	CcSEcCtD
Tamoxifen—Anorexia—Prednisone—Crohn's disease	0.000344	0.00096	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000329	0.000918	CcSEcCtD
Tamoxifen—Insomnia—Prednisone—Crohn's disease	0.000326	0.000911	CcSEcCtD
Tamoxifen—Paraesthesia—Prednisone—Crohn's disease	0.000324	0.000905	CcSEcCtD
Tamoxifen—Dyspepsia—Prednisone—Crohn's disease	0.000318	0.000887	CcSEcCtD
Tamoxifen—Decreased appetite—Prednisone—Crohn's disease	0.000314	0.000876	CcSEcCtD
Tamoxifen—Fatigue—Prednisone—Crohn's disease	0.000311	0.000869	CcSEcCtD
Tamoxifen—Constipation—Prednisone—Crohn's disease	0.000308	0.000862	CcSEcCtD
Tamoxifen—ABCB1—lymph node—Crohn's disease	0.000302	0.00168	CbGeAlD
Tamoxifen—Gastrointestinal pain—Prednisone—Crohn's disease	0.000295	0.000824	CcSEcCtD
Tamoxifen—Urticaria—Prednisone—Crohn's disease	0.000287	0.0008	CcSEcCtD
Tamoxifen—Abdominal pain—Prednisone—Crohn's disease	0.000285	0.000796	CcSEcCtD
Tamoxifen—Hypersensitivity—Prednisone—Crohn's disease	0.000266	0.000742	CcSEcCtD
Tamoxifen—Asthenia—Prednisone—Crohn's disease	0.000259	0.000723	CcSEcCtD
Tamoxifen—Pruritus—Prednisone—Crohn's disease	0.000255	0.000713	CcSEcCtD
Tamoxifen—Diarrhoea—Prednisone—Crohn's disease	0.000247	0.000689	CcSEcCtD
Tamoxifen—Dizziness—Prednisone—Crohn's disease	0.000239	0.000666	CcSEcCtD
Tamoxifen—Vomiting—Prednisone—Crohn's disease	0.000229	0.000641	CcSEcCtD
Tamoxifen—Rash—Prednisone—Crohn's disease	0.000227	0.000635	CcSEcCtD
Tamoxifen—Dermatitis—Prednisone—Crohn's disease	0.000227	0.000635	CcSEcCtD
Tamoxifen—Headache—Prednisone—Crohn's disease	0.000226	0.000631	CcSEcCtD
Tamoxifen—Nausea—Prednisone—Crohn's disease	0.000214	0.000598	CcSEcCtD
Tamoxifen—FMO3—Metabolism—GPX4—Crohn's disease	5.74e-05	0.00151	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PLA2G4F—Crohn's disease	5.72e-05	0.0015	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—STAT3—Crohn's disease	5.71e-05	0.0015	CbGpPWpGaD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.64e-05	0.00148	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.56e-05	0.00146	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GCKR—Crohn's disease	5.54e-05	0.00146	CbGpPWpGaD
Tamoxifen—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	5.49e-05	0.00144	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—TNF—Crohn's disease	5.45e-05	0.00143	CbGpPWpGaD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—IL6—Crohn's disease	5.32e-05	0.0014	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.27e-05	0.00138	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.15e-05	0.00135	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—FADS1—Crohn's disease	5.14e-05	0.00135	CbGpPWpGaD
Tamoxifen—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	5e-05	0.00131	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.91e-05	0.00129	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.88e-05	0.00128	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—MTMR3—Crohn's disease	4.86e-05	0.00128	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	4.84e-05	0.00127	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	4.84e-05	0.00127	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.83e-05	0.00127	CbGpPWpGaD
Tamoxifen—ESR1—ATF-2 transcription factor network—IL6—Crohn's disease	4.83e-05	0.00127	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GPX4—Crohn's disease	4.81e-05	0.00126	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	4.77e-05	0.00125	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.7e-05	0.00123	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GCKR—Crohn's disease	4.65e-05	0.00122	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.64e-05	0.00122	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—TYK2—Crohn's disease	4.63e-05	0.00122	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	4.57e-05	0.0012	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.51e-05	0.00118	CbGpPWpGaD
Tamoxifen—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	4.5e-05	0.00118	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.48e-05	0.00118	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—HSPA1B—Crohn's disease	4.47e-05	0.00117	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—JAK2—Crohn's disease	4.42e-05	0.00116	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—SMAD3—Crohn's disease	4.41e-05	0.00116	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—IL6—Crohn's disease	4.4e-05	0.00116	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PLA2G4F—Crohn's disease	4.31e-05	0.00113	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.29e-05	0.00113	CbGpPWpGaD
Tamoxifen—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.28e-05	0.00112	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.27e-05	0.00112	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	4.25e-05	0.00112	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—IL6—Crohn's disease	4.21e-05	0.00111	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PLA2G4F—Crohn's disease	4.15e-05	0.00109	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	4.14e-05	0.00109	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—UBE2D1—Crohn's disease	4.11e-05	0.00108	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4e-05	0.00105	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—ZFP36L1—Crohn's disease	3.93e-05	0.00103	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—UBE2D1—Crohn's disease	3.92e-05	0.00103	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—IFNG—Crohn's disease	3.87e-05	0.00102	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.81e-05	0.001	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—FADS1—Crohn's disease	3.79e-05	0.000995	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PLA2G4F—Crohn's disease	3.78e-05	0.000993	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	3.75e-05	0.000984	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ACKR2—Crohn's disease	3.72e-05	0.000978	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.71e-05	0.000975	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.71e-05	0.000975	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—MTMR3—Crohn's disease	3.67e-05	0.000964	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.66e-05	0.000962	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.64e-05	0.000957	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	3.6e-05	0.000946	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.56e-05	0.000936	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GPX4—Crohn's disease	3.55e-05	0.000932	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—MTMR3—Crohn's disease	3.53e-05	0.000928	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MLN—Crohn's disease	3.53e-05	0.000928	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.49e-05	0.000917	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.46e-05	0.00091	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—IL1B—Crohn's disease	3.46e-05	0.000908	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PLA2G4F—Crohn's disease	3.43e-05	0.000902	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GCKR—Crohn's disease	3.43e-05	0.0009	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—DNMT3A—Crohn's disease	3.34e-05	0.000877	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.27e-05	0.000858	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TAGAP—Crohn's disease	3.23e-05	0.000848	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—MTMR3—Crohn's disease	3.21e-05	0.000844	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—MTMR3—Crohn's disease	3.19e-05	0.000837	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.11e-05	0.000818	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.11e-05	0.000818	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	3.09e-05	0.00081	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	3.09e-05	0.00081	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—ALB—Crohn's disease	3.03e-05	0.000795	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—ALB—Crohn's disease	2.97e-05	0.000781	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—SMAD3—Crohn's disease	2.94e-05	0.000772	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—MTMR3—Crohn's disease	2.92e-05	0.000767	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.92e-05	0.000766	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—ALB—Crohn's disease	2.87e-05	0.000754	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—FADS1—Crohn's disease	2.86e-05	0.000751	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.84e-05	0.000746	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RSPO3—Crohn's disease	2.82e-05	0.000742	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—SMAD3—Crohn's disease	2.81e-05	0.000737	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	2.77e-05	0.000728	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—FADS1—Crohn's disease	2.75e-05	0.000723	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	2.71e-05	0.000713	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	2.71e-05	0.000711	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GPX4—Crohn's disease	2.68e-05	0.000703	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SEL1L—Crohn's disease	2.68e-05	0.000703	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.66e-05	0.000698	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PTGS2—Crohn's disease	2.65e-05	0.000696	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.61e-05	0.000687	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PTGS2—Crohn's disease	2.6e-05	0.000683	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GCKR—Crohn's disease	2.58e-05	0.000679	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GPX4—Crohn's disease	2.58e-05	0.000677	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	2.56e-05	0.000672	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PTGS2—Crohn's disease	2.51e-05	0.00066	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—TNF—Crohn's disease	2.51e-05	0.000659	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—FADS1—Crohn's disease	2.5e-05	0.000658	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GCKR—Crohn's disease	2.49e-05	0.000654	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—FADS1—Crohn's disease	2.48e-05	0.000652	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—ALB—Crohn's disease	2.47e-05	0.000648	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.45e-05	0.000643	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCR9—Crohn's disease	2.45e-05	0.000643	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.43e-05	0.000637	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—MTMR3—Crohn's disease	2.36e-05	0.000619	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	2.35e-05	0.000616	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GPX4—Crohn's disease	2.34e-05	0.000616	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.34e-05	0.000614	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GPX4—Crohn's disease	2.32e-05	0.00061	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.31e-05	0.000607	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—MTMR3—Crohn's disease	2.31e-05	0.000606	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—MTMR3—Crohn's disease	2.3e-05	0.000605	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—ALB—Crohn's disease	2.29e-05	0.000603	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GPR65—Crohn's disease	2.28e-05	0.000598	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—FADS1—Crohn's disease	2.27e-05	0.000598	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.27e-05	0.000597	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—IL6—Crohn's disease	2.27e-05	0.000595	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GCKR—Crohn's disease	2.26e-05	0.000595	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—HSPA1B—Crohn's disease	2.26e-05	0.000592	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GCKR—Crohn's disease	2.24e-05	0.00059	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MTMR3—Crohn's disease	2.18e-05	0.000571	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PTGS2—Crohn's disease	2.16e-05	0.000567	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.14e-05	0.000563	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GPX4—Crohn's disease	2.13e-05	0.00056	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	2.09e-05	0.00055	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GCKR—Crohn's disease	2.06e-05	0.00054	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PLA2G4F—Crohn's disease	2.04e-05	0.000537	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PTGS2—Crohn's disease	2.01e-05	0.000527	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MTMR3—Crohn's disease	1.99e-05	0.000524	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—UBE2D1—Crohn's disease	1.98e-05	0.000519	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	1.93e-05	0.000506	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.91e-05	0.000501	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.85e-05	0.000485	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—FADS1—Crohn's disease	1.84e-05	0.000482	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.83e-05	0.000481	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—FADS1—Crohn's disease	1.8e-05	0.000472	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—FADS1—Crohn's disease	1.79e-05	0.000471	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTMR3—Crohn's disease	1.78e-05	0.000468	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.78e-05	0.000467	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.77e-05	0.000465	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ALB—Crohn's disease	1.76e-05	0.000464	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTMR3—Crohn's disease	1.74e-05	0.000456	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GPX4—Crohn's disease	1.72e-05	0.000451	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—FADS1—Crohn's disease	1.69e-05	0.000445	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GPX4—Crohn's disease	1.68e-05	0.000442	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GPX4—Crohn's disease	1.68e-05	0.000441	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GCKR—Crohn's disease	1.66e-05	0.000436	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.64e-05	0.00043	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.63e-05	0.000429	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GCKR—Crohn's disease	1.63e-05	0.000427	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTMR3—Crohn's disease	1.62e-05	0.000426	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GCKR—Crohn's disease	1.62e-05	0.000426	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCR6—Crohn's disease	1.62e-05	0.000426	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.62e-05	0.000424	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GPX4—Crohn's disease	1.59e-05	0.000417	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.56e-05	0.000409	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—FADS1—Crohn's disease	1.55e-05	0.000408	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PTGS2—Crohn's disease	1.54e-05	0.000406	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.54e-05	0.000404	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GCKR—Crohn's disease	1.53e-05	0.000403	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ALB—Crohn's disease	1.48e-05	0.000388	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RBX1—Crohn's disease	1.47e-05	0.000385	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GPX4—Crohn's disease	1.45e-05	0.000382	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTGER4—Crohn's disease	1.43e-05	0.000375	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—SMAD3—Crohn's disease	1.41e-05	0.000372	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GCKR—Crohn's disease	1.41e-05	0.000369	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTMR3—Crohn's disease	1.39e-05	0.000364	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—FADS1—Crohn's disease	1.39e-05	0.000364	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—FADS1—Crohn's disease	1.35e-05	0.000356	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GPX4—Crohn's disease	1.3e-05	0.000341	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PTGS2—Crohn's disease	1.29e-05	0.00034	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—UBE2D1—Crohn's disease	1.29e-05	0.000338	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—FADS1—Crohn's disease	1.28e-05	0.000335	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GPX4—Crohn's disease	1.27e-05	0.000333	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—FADS1—Crohn's disease	1.26e-05	0.000332	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.26e-05	0.000331	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GCKR—Crohn's disease	1.25e-05	0.000329	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RIPK2—Crohn's disease	1.25e-05	0.000328	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.24e-05	0.000325	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GCKR—Crohn's disease	1.22e-05	0.000322	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL3—Crohn's disease	1.22e-05	0.000319	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GPX4—Crohn's disease	1.19e-05	0.000314	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GPX4—Crohn's disease	1.18e-05	0.000311	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RASGRP1—Crohn's disease	1.18e-05	0.000309	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GCKR—Crohn's disease	1.15e-05	0.000303	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GCKR—Crohn's disease	1.14e-05	0.0003	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.1e-05	0.000288	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ALB—Crohn's disease	1.09e-05	0.000286	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—FADS1—Crohn's disease	1.08e-05	0.000284	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.07e-05	0.000281	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SOCS1—Crohn's disease	1.07e-05	0.00028	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GPX4—Crohn's disease	1.01e-05	0.000266	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1e-05	0.000264	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GCKR—Crohn's disease	9.77e-06	0.000257	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9.58e-06	0.000252	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTGS2—Crohn's disease	9.54e-06	0.000251	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SMAD3—Crohn's disease	9.2e-06	0.000242	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.96e-06	0.000235	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.79e-06	0.000231	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2RA—Crohn's disease	8.52e-06	0.000224	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—FADS1—Crohn's disease	8.34e-06	0.000219	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	8.32e-06	0.000219	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ALB—Crohn's disease	8.23e-06	0.000216	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.17e-06	0.000215	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ALB—Crohn's disease	7.92e-06	0.000208	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.84e-06	0.000206	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GPX4—Crohn's disease	7.81e-06	0.000205	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GCKR—Crohn's disease	7.54e-06	0.000198	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ALB—Crohn's disease	7.21e-06	0.000189	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—Crohn's disease	7.2e-06	0.000189	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.15e-06	0.000188	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ALB—Crohn's disease	7.14e-06	0.000188	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.98e-06	0.000183	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—Crohn's disease	6.93e-06	0.000182	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ALB—Crohn's disease	6.55e-06	0.000172	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—Crohn's disease	6.3e-06	0.000166	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—Crohn's disease	6.25e-06	0.000164	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.11e-06	0.000161	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TYK2—Crohn's disease	6e-06	0.000158	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—Crohn's disease	5.73e-06	0.00015	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JAK2—Crohn's disease	5.72e-06	0.00015	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—Crohn's disease	5.28e-06	0.000139	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL8—Crohn's disease	5.22e-06	0.000137	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—Crohn's disease	5.17e-06	0.000136	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—Crohn's disease	5.16e-06	0.000136	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—Crohn's disease	4.88e-06	0.000128	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—Crohn's disease	4.62e-06	0.000121	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—Crohn's disease	4.53e-06	0.000119	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—Crohn's disease	4.52e-06	0.000119	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—Crohn's disease	4.47e-06	0.000117	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—Crohn's disease	4.27e-06	0.000112	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—Crohn's disease	4.2e-06	0.00011	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—Crohn's disease	3.99e-06	0.000105	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—Crohn's disease	3.91e-06	0.000103	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—Crohn's disease	3.9e-06	0.000102	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—Crohn's disease	3.67e-06	9.64e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—Crohn's disease	3.64e-06	9.56e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—Crohn's disease	3.49e-06	9.17e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—Crohn's disease	3.41e-06	8.95e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—Crohn's disease	3.21e-06	8.44e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—Crohn's disease	3.18e-06	8.37e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—Crohn's disease	3.11e-06	8.17e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—Crohn's disease	2.93e-06	7.71e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.72e-06	7.15e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—Crohn's disease	2.4e-06	6.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.1e-06	5.52e-05	CbGpPWpGaD
